跳至主要内容
临床试验/NCT05862961
NCT05862961尚未招募不适用

Towards a Better Classification of Respiratory Amyloidosis. Contribution of Proteomic Analysis Based on Tandem Mass Spectrometry

Assistance Publique - Hôpitaux de Paris0 个研究点目标入组 70 人开始时间: 2023年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
70
主要终点
Number of cases with identification of the amylogenic protein in respiratory amyloidosis.

研究概览

简要总结

The B-AR project is based on a retrospective analysis of amyloidosis typing and the identification of their amylogenic protein.This work should be able to unite many clinicians, including pulmonologists and pathologists around a rare disease that still suffers from insufficient data.

详细描述

The B-AR study will highlight the interest of proteomic analysis of amyloidosis compared to their identification by immunostaining. The objective is to reduce diagnostic wandering and to improve patient management. The typing of respiratory amyloidosis will allow a better characterization of the disease and thus, to propose a dedicated therapeutic management.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient > to 18 years with amyloidosis on a histological sample of the tracheobronchial or pulmonary tree.

排除标准

  • Subject receiving state medical aid
  • Subject deprived of freedom, or under a legal protective measure (example: patients under guardianship or curators)

结局指标

主要结局

Number of cases with identification of the amylogenic protein in respiratory amyloidosis.

时间窗: 1 day (at inclusion)

Identification of amylogenic protein by Proteomic Analysis Based on Tandem Mass Spectrometry on histological sample of the tracheobronchial or pulmonary tree.

次要结局

  • Distribution and severity of amyloidosis(1 day (at inclusion))

研究者

申办方类型
Other
责任方
Sponsor

相似试验